Acorn Biolabs Featured in The Hollywood Reporter: Why Hollywood Is Banking on Its Own Hair

The Hollywood Reporter set out to explain why follicle banking has quietly become the hair restoration strategy of choice among celebrities and the experts who treat them, Acorn Biolabs was one of the names that came up. The piece, "Why Hollywood's Follicle-Challenged Stars Are Harvesting Their Hair," captures a real shift in how people are thinking about hair loss, and it's worth unpacking where Acorn fits in. 

For decades, anyone facing hair loss had two real options: medication or a transplant, both with mixed results. That conversation is changing. With a new generation of hair growth drugs still years away from possible FDA approval, the smarter play, experts say, isn't to chase tomorrow's treatment today. It's preserving your own healthy follicle cells now, so they're ready when those regenerative therapies finally arrive.

Dr. Alan J. Bauman, one of the country's leading hair restoration physicians, calls hair follicle multiplication the "holy grail of hair restoration," a technology that could one day produce unlimited, genetically matched follicles and finally break free of the donor limitations that have always capped what a transplant can do. Bauman has banked his own follicles and receives celebrity inquiries every week.

Where Acorn Comes In

Acorn Biolabs is listed among the leaders in this space, and the process is simple:

• Collection: About 50 healthy hair follicles are harvested during a 30-minute, non-invasive procedure without anesthesia.
• Preservation: The follicles are lab-tested and cryogenically preserved for future use.
• Personalized secretome: Beyond banking, Acorn can create a custom secretome from your own cells: a concentrated blend of growth factors, exosomes, cytokines, and peptides that deliver repair signals to the scalp via microneedling.

The Field Is Moving Fast

After nearly 30 years stuck with just two FDA-approved hair loss products, new drugs are moving through clinical trials, exosome therapies are gaining real traction, and follicle cloning could become reality within the decade.

The through-line is hard to miss. Every one of those future breakthroughs will depend on healthy cells to work with. And here's the part worth sitting with: your cells will never be younger than they are right now.

Read the full feature at The Hollywood Reporter, or take our secretome quiz to see where you'd start.